The Global Critical Care Diagnostics market is accounted for $0.86 billion in 2016 and is expected to reach $1.34 billion by 2023 growing at a CAGR of 6.5% from 2016 to 2023

Friday, January 12, 2018 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Jan. 11, 2018 /PRNewswire/ -- According to Stratistics MRC, the Global Critical Care Diagnostics market is accounted

for $0.86 billion in 2016 and is expected to reach $1.34 billion by 2023 growing at a CAGR of 6.5% from 2016 to 2023. Download the full report: Growing
aging population and chronic health concerns, improving advancements in technologies and rapid attentiveness, increasing acceptance of these tests by physicians and patients are some of factors triggering the market growth. Furthermore, growing incidence of chronic disease such as cancer, heart disease, and diabetes are fuelling the market growth. However, increased price of the molecular diagnostics and shortage of skilled professionals are some of the factors restraining the market growth. Microbial and Infectious diseases test segment is anticipated to grow at the highest CAGR during the forecast period. The growth is owing to the quick and accurate test results to diagnose the disease. Immunoproteins diagnostic test segment accounted for largest market revenue due to increase massive demand for early disease diagnosis. North America represents as the largest market in terms of revenue. High research and development activities, higher demand from U.S boosting the North America market. Asia Pacific is projected to dominate the global market in terms of revenue due to rising specialty hospitals and convalescing healthcare services and infrastructures in rural areas. Some of the key players profiled in this market include Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, Beckman Coulter, Becton Dickinson & Co., BioMerieux, Inc., Bio-Rad Laboratories, Biosensors Japan, Chembio Diagnostic Systems, Inc., EKF Diagnostics, Nanomix Inx., Nova Biomedical, Roche Diagnostics Ltd., Siemens Healthcare Diagnostics, and Sysmex Corporation. Product Types Covered: • Cancer markers testing kit • Cardiometabolic monitoring kits • Fecal Occult testing kits • Drugs-Of-Abuse testing kits • Coagulation monitoring kits • Cholesterol test strips • Glucose monitoring kits • Pregnancy and fertility testing kits • Infectious Disease testing kits • Hematology testing kits • Other critical care diagnostics testing kits Test Types Covered: • Hematology • Coagulation • Routine & Special Chemistry • Microbial & Infectious Test • Flow Cytometry • Immunoproteins • Other Test Types Prescription Modes Covered: • OTC Testing Kits • Prescription-Based Testing Kits End Users Covered: • Ambulatory surgical centers • Home • Hospitals • Research Laboratories Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o UK o Italy o France o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o South Korea o Rest of Asia Pacific • South America o Argentina o Brazil o Chile o Rest of South America • Middle East & Africa o Saudi Arabia o UAE o Qatar o South Africa o Rest of Middle East & Africa What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancementsDownload the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email:  Tel: +1 (646) 453 6293 Website:  

Cision View original content:

SOURCE ReportBuyer


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store